BIOGEN INC. Quarterly Nonoperating Income (Expense) in USD from Q2 2014 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Biogen Inc. annual/quarterly Nonoperating Income (Expense) history and growth rate from Q2 2014 to Q1 2022.
  • Biogen Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2022 was -$263M, a 48.1% increase year-over-year.
  • Biogen Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2022 was -$852M, a 867% decline year-over-year.
  • Biogen Inc. annual Nonoperating Income (Expense) for 2023 was -$316M, a 392% decline from 2022.
  • Biogen Inc. annual Nonoperating Income (Expense) for 2022 was $108M.
  • Biogen Inc. annual Nonoperating Income (Expense) for 2021 was -$1.1B, a 320% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 -$852M -$263M +$244M +48.1% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-03
Q4 2021 -$1.1B -$182M -$866M -127% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-14
Q3 2021 -$230M -$503M -$374M -291% Jul 1, 2021 Sep 30, 2021 10-Q 2021-10-20
Q2 2021 $144M $96.4M +$33.4M +53% Apr 1, 2021 Jun 30, 2021 10-Q 2021-07-22
Q1 2021 $111M -$507M -$386M -321% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $497M $684M +$733M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-15
Q3 2020 -$235M -$129M -$101M -371% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-20
Q2 2020 -$134M $63M +$260M Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-22
Q1 2020 -$395M -$121M -$478M -134% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-22
Q4 2019 $83.3M -$49.3M -$20.7M -72.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-03
Q3 2019 $104M -$27.3M -$142M -124% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-21
Q2 2019 $246M -$197M -$163M -472% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-22
Q1 2019 $409M $357M +$398M Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-23
Q4 2018 $11M -$28.6M +$37.8M +56.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-03
Q3 2018 -$26.8M $115M +$159M Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-22
Q2 2018 -$186M -$34.5M +$34.1M +49.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-24
Q1 2018 -$220M -$41M -$3M -7.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-24
Q4 2017 -$217M -$66.4M -$17.1M -34.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-06
Q3 2017 -$200M -$44M +$14.1M +24.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-23
Q2 2017 -$214M -$68.6M -$10.1M -17.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-24
Q1 2017 -$204M -$38M +$14.8M +28% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-24
Q4 2016 -$219M -$49.3M +$33.1M +40.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-06
Q3 2016 -$252M -$58.1M -$42.7M -277% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-24
Q2 2016 -$209M -$58.5M -$47.6M -437% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-25
Q1 2016 -$162M -$52.8M -$37.8M -252% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-25
Q4 2015 -$124M -$82.4M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-01
Q3 2015 -$15.4M +$890K +5.46% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-26
Q2 2015 -$10.9M -$15.8M -324% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-21
Q1 2015 -$15M Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-21
Q3 2014 -$16.3M Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-21
Q2 2014 $4.86M Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.